» Articles » PMID: 2064198

Establishment and Characterization of Human Endometrial Cancer Cell Lines

Overview
Specialty Science
Date 1991 Jan 1
PMID 2064198
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities.

Zhang X, Joseph S, Wu D, Bowser J, Vaziri C NAR Cancer. 2024; 6(2):zcae015.

PMID: 38596432 PMC: 11000323. DOI: 10.1093/narcan/zcae015.


High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.

Urick M, Yu E, Bell D Cancer. 2021; 127(16):2905-2915.

PMID: 33872388 PMC: 8319067. DOI: 10.1002/cncr.33567.


Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer.

Kurnit K, Draisey A, Kazen R, Chung C, Phan L, Harvey J Cancer Lett. 2021; 505:75-86.

PMID: 33609609 PMC: 9812391. DOI: 10.1016/j.canlet.2021.01.030.


Genomic characterization of five commonly used endometrial cancer cell lines.

Devor E, Gonzalez-Bosquet J, Thiel K, Leslie K Int J Oncol. 2020; 57(6):1348-1357.

PMID: 33174010 PMC: 8811471. DOI: 10.3892/ijo.2020.5139.


LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer.

Kunitomi H, Kobayashi Y, Wu R, Takeda T, Tominaga E, Banno K J Gynecol Oncol. 2020; 31(2):e11.

PMID: 31912669 PMC: 7044014. DOI: 10.3802/jgo.2020.31.e11.